Job was saved successfully.
Job was removed from Saved Jobs.

Job Details


Daiichi Sankyo, Inc.

Sr. Director Early Oncology Asset Leader - Global Clinical Sciences (R685)

Pharmaceuticals

All

Yearly

Full Time

No

Bernards, New Jersey, United States

Job Description

Join a Legacy of Innovation 110 Years and Counting!

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.


Summary

This position is a Clinical Science lead position and will lead a group of clinical scientists organized around one or more clinical stage assets (including those at the pre-IND stage) within the Global Clinical Science function. This position may be at the executive director level or senior director level, depending on the scope and size of the asset program.

This Clinical Science (CS) lead will be responsible for leading and managing one or more clinical scientists, oversee a program of clinical trials from the clinical science perspective, and ensure the writing of high quality clinical trial protocols, review of clinical data and Clinical Study Reports (CSRs)/outputs throughout the project life cycle. The CS lead will also contribute to the program study strategy, planning, execution and reporting outputs. CS lead responsibilities include overseeing the CS direct reports who will be responsible for the writing of protocols / amendments and associated documents (writing of ICF, DM charter, response assessment charter, etc), clinical data review excellence with a focus on patient safety and data integrity, site scientific engagement, and HA responses. Interactions with the internal clinical study physicians and physician scientists as well as external investigators is expected. Depending upon team composition and scope of program, the CS lead may also be responsible for study level clinical sciences responsibilities, as well as clinical and safety monitoring under direct guidance of a physician (Global Clinical Leader or Physician Scientist).

The clinical science lead will also participate in the creation and management of new clinical science group from existing pool of clinical scientists, formulate a structure and a resourcing plan, and develop capabilities to serve the needs of the enterprise based on a vision for the function.

As a member of the Global Project Team (GPT), the incumbent closely collaborates with the Global Clinical Lead (GCL), the Global Team Leader (GTL), and other members of the GPT and key stakeholders and leaders across the Global Daiichi Sankyo R&D organization to achieve desired business results (short-term, mid-term, long-term).

Responsibilities

  • Accountable for developing the Global (Oncology) Clinical Science Strategy and delivery of clinical studies for one or several oncology assets:
    • Lead and manage a group of clinical scientists organized around one or more assets or therapeutic areas, including integration of regionally based CS’s into a single global CS organization.
    • Ensure that adequate (Oncology) Clinical Science resources are deployed to clinical studies from end to end in collaboration with Physician Scientists and the study team (data management, clinical operation and other functions) to implement clinical development plan: study ideation, protocol development, review case report from creation, study initiation, study conduct and oversight (study monitoring, tracking of clinical data), database lock, creating Clinical Study Report, and submission to the Health Authorities.
    • Ensure that CS’s within their group receive the necessary training, coaching and support to fulfil their role.
    • Work with GCL (and GTL) to ensure consistency in support between studies in one or several programs.
    • Partner and collaborate with Clinical Operations, Biostatistics and Data Management, Regulatory Affairs and other R&D functions to ensure effective delivery of one or several oncology assets.
    • Ensure alignment with other key peer functions outside R&D (in particular CSPV, QA, and other functions as Pharm Tech SC and biologics, Corporate Business Management)
    • Partner and collaborate with global marketing, global medical affairs, global payers and access and commercial business units to ensure unified Global (Oncology) Clinical Science Strategy.
    • In conjunction with Global R&D Finance, Global Project Management, HR, manage the workforce planning for Global (oncology) Clinical Science, operating and capital budgets, resource planning and resource allocation.
  • Create a performance-based team culture with clear accountability and a sense of urgency for achieving results. Lead (recruit, hire, coach, develop, motivate, manage and monitor performance) managers and/or professionals in department specific knowledge, process and procedures. Sets clear job expectations, provides regular feedback, conducts timely Performance Plan reviews, identifies performance challenges, creates action plans and monitor the effectiveness of those action plans. Complete Career Planning and competency assessment to ensure professional development of department members.
  • Ensure that CS are maintaining up to date knowledge of all-important advances within oncology through scientific literature, attendance at critical meetings and relationships with Key External Experts (KEEs). Contributes to clinical/scientific training of relevant DS stakeholders on the disease area and compound/Drug. May serve as speaker for program/ franchise medical/scientific training
  • Guide the Clinical Science staff in the creation of the development strategy ensuring the highest scientific/medical standards in accordance with ethical and regulatory requirements across regions.
  • Interact with clinical investigators, academic organizations, co-development partners, and strategic outsourcing.
  • Contribute to Clinical (oncology) Development initiatives, global education and process development projects, as required.
    May serve on or lead global initiatives (e.g., process improvement, Protocol review, training, SOP development, other Clinical (oncology) Development line function initiatives) and represent the function on various leadership teams and committees.


Qualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.
Education Qualifications (from an accredited college or university)

  • Master's Degree or equivalent preferred
  • PharmD or equivalent preferred
  • PharmD or equivalent preferred
  • Postgraduate training in oncology or related specialty, or equivalent preferred

Experience Qualifications

  • 7 or More Years relevant clinical oncology experience preferred

Travel Ability to travel up to 30% In-house office position that may require travel (global).

Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.